Children's recognized vulnerability to the adverse effects of hospitalization has resulted in the firm belief that minimization or avoidance of hospitalization is in children's best interests. For children with newly diagnosed diabetes, minimal hospitalization may be achieved through the flexibility of the paediatric diabetes specialist nurse role, which crosses the boundary between hospital and community. This study was undertaken to evaluate the effectiveness of a paediatric diabetes specialist nurse in reducing the length of hospitalization for newly diagnosed children. Using a quantitative approach, a quasi-experimental research design was chosen, measuring the length of hospitalization at diagnosis for 40 children diagnosed in the 2 years preceding, and 16 children diagnosed in the 9 months following, the commencement of the paediatric diabetes specialist nurse post. The study findings showed a significant reduction in the length of hospitalization, suggesting that paediatric diabetes specialist nurses, by minimizing or avoiding hospitalization for newly diagnosed children, can make a substantial contribution to their emotional wellbeing.
Aim: This paper is a report of a study to describe nurses' perceptions of decisionmaking and the evidence-base for the initiation of insulin therapy.Background: Several theoretical perspectives and professional's attributes underpin
The study provides an insight into current insulin initiation practice in childhood diabetes and offers a useful comparator as practices change in the light of advances in treatment (medication and equipment), changes in professional roles (e.g. independent prescribing) and policy shifts (the move away from hospitals and resource constraints).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.